Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism Prostaglandin agonists |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC26H18N2O5 |
InChIKeyDSRSEEYZGWTODH-UHFFFAOYSA-N |
CAS Registry152575-66-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Prostatic Cancer | Preclinical | CN | 01 Feb 2000 |